Chertow GM - Search Results

1

Targeting Vascular Calcification in Chronic Kidney Disease.

Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Nelson AJ, et al. Among authors: chertow gm. JACC Basic Transl Sci. 2020 Apr 27;5(4):398-412. doi: 10.1016/j.jacbts.2020.02.002. eCollection 2020 Apr. JACC Basic Transl Sci. 2020. PMID: 32368697 Free PMC article. Review.

2

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM. Raggi P, et al. Among authors: chertow gm. J Am Coll Cardiol. 2002 Feb 20;39(4):695-701. doi: 10.1016/s0735-1097(01)01781-8. J Am Coll Cardiol. 2002. PMID: 11849871 Free article.

3

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.

Chertow GM, Burke SK, Raggi P; Treat to Goal Working Group. Chertow GM, et al. Kidney Int. 2002 Jul;62(1):245-52. doi: 10.1046/j.1523-1755.2002.00434.x. Kidney Int. 2002. PMID: 12081584 Free article. Clinical Trial.

4

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.

Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD. Chertow GM, et al. Am J Nephrol. 2003 Sep-Oct;23(5):307-14. doi: 10.1159/000072822. Epub 2003 Aug 12. Am J Nephrol. 2003. PMID: 12915774 Free article. Clinical Trial.

5

Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.

Raggi P, Bommer J, Chertow GM. Raggi P, et al. Among authors: chertow gm. J Heart Valve Dis. 2004 Jan;13(1):134-41. J Heart Valve Dis. 2004. PMID: 14765851 Clinical Trial.

6

Determinants of progressive vascular calcification in haemodialysis patients.

Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK. Chertow GM, et al. Nephrol Dial Transplant. 2004 Jun;19(6):1489-96. doi: 10.1093/ndt/gfh125. Epub 2004 Apr 21. Nephrol Dial Transplant. 2004. PMID: 15102961

7

Screening to prevent coronary events or screening to detect obstruction?

Raggi P, Budoff MJ, Chertow GM. Raggi P, et al. Among authors: chertow gm. Am J Kidney Dis. 2004 May;43(5):940; author reply 940-1. doi: 10.1053/j.ajkd.2004.03.014. Am J Kidney Dis. 2004. PMID: 15112188 No abstract available.

8

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.

Garg JP, Chasan-Taber S, Blair A, Plone M, Bommer J, Raggi P, Chertow GM. Garg JP, et al. Among authors: chertow gm. Arthritis Rheum. 2005 Jan;52(1):290-5. doi: 10.1002/art.20781. Arthritis Rheum. 2005. PMID: 15641045 Free article. Clinical Trial.

9

Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.

Ferramosca E, Burke S, Chasan-Taber S, Ratti C, Chertow GM, Raggi P. Ferramosca E, et al. Among authors: chertow gm. Am Heart J. 2005 May;149(5):820-5. doi: 10.1016/j.ahj.2004.07.023. Am Heart J. 2005. PMID: 15894962

10

Coronary and aortic calcifications in patients new to dialysis.

Spiegel DM, Raggi P, Mehta R, Lindberg JS, Chonchol M, Ehrlich J, James G, Chertow GM, Block GA. Spiegel DM, et al. Among authors: chertow gm. Hemodial Int. 2004 Jul 1;8(3):265-72. doi: 10.1111/j.1492-7535.2004.01104.x. Hemodial Int. 2004. PMID: 19379426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

847 results

Search Page

Filters